- idUS
- Listar por autor
Listar por autor "Herrera, Pilar"
Mostrando ítems 1-3 de 3
-
Artículo
Outcomes after intensive chemotherapy for secondary and myeloid-related changes acute myeloid leukemia patients aged 60 to 75 years old: a retrospective analysis from the PETHEMA registry
Martínez-Cuadrón, David; Megías-Vericat, Juan E.; Gil, Cristina; Bernal, Teresa; Tormo, Mar; Martínez-Sánchez, Pilar; Rodríguez-Medina, Carlos; Serrano, Josefina; Herrera, Pilar; Pérez Simón, José Antonio (Ferrata Storti Foundation, 2024)Treatment options for patients with secondary acute myeloid leukemia (sAML) and AML with myeloid-related changes (AMLMRC) ...
-
Artículo
Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study
Ocio, Enrique M.; Herrera, Pilar; Olave, María Teresa; Castro, Nerea; Pérez Simón, José Antonio; Brunet, Salut; Oriol, Albert; San Miguel, Jesús F. (Ferrata Storti Foundation, 2015)This phase Ib/II trial combined the pan-deacetylase inhibitor panobinostat with chemotherapy followed by panobinostat ...
-
Artículo
Phase II Trial of Allogeneic Transplantation Plus Novel Drugs in Multiple Myeloma: Effect of Intensifying Reduced-Intensity Conditioning with Bortezomib and Adding Maintenance Treatment
Reinoso-Segura, Marta; Caballero Velázquez, Teresa; Herrera, Pilar; Patriarca, Francesca; Herrera, Pilar; Fanin, Renato; Bruno, Benedetto; Gahrton, Gösta; Pérez Simón, José Antonio (Elsevier Inc., 2022)The use of reduced-intensity conditioning (RIC) regimens has decreased the risk of nonrelapse mortality (NRM) after ...